The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.

Abstract

BACKGROUND:

Mutations in TNFRSF13B, the gene encoding transmembrane activator and calcium modulator cyclophilin ligand interactor (TACI), are found in 10% of patients with common variable immunodeficiency. However, the most commonly detected mutation is the heterozygous change C104R, which is also found in 0.5% to 1% of healthy subjects. The contribution of the C104R mutation to the B-cell defects observed in patients with common variable immunodeficiency therefore remains unclear.

OBJECTIVE:

We sought to define the functional consequences of the C104R mutation on B-cell function.

METHODS:

We performed in vitro studies of TACI C104R expression and signaling. A knock-in mouse with the equivalent mutation murine TACI (mTACI) C76R was generated as a physiologically relevant model of human disease. We examined homozygous and heterozygous C76R mutant mice alongside wild-type littermates and studied specific B-cell lineages and antibody responses to T cell-independent and T cell-dependent challenge.

RESULTS:

C104R expression and ligand binding are significantly diminished when the mutant protein is expressed in 293T cells or in patients' cell lines. This leads to defective nuclear factor κB activation, which is proportionally restored by reintroduction of wild-type TACI. Mice heterozygous and homozygous for mTACI C76R exhibit significant B-cell dysfunction with splenomegaly, marginal zone B-cell expansion, diminished immunoglobulin production and serological responses to T cell-independent antigen, and abnormal immunoglobulin synthesis.

CONCLUSIONS:

These data show that the C104R mutation and its murine equivalent, C76R, can significantly disrupt TACI function, probably through haploinsufficiency. Furthermore, the heterozygous C76R mutation alone is sufficient to disturb B-cell function with lymphoproliferation and immunoglobulin production defects.

• Authors: Chiara Bacchelli, Karen F Buckland, Sylvie Buckridge, Ulrich Salzer, Pascal Schneider, Adrian J Thrasher, H Bobby Gaspar
• Journal: The Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 127 Issue 5 Pg. 1253-9.e13 (May 2011) ISSN: 1097-6825 [Electronic] United States
• PMID: 21458042 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Chemical References

• Transmembrane Activator and CAML Interactor Protein

Topics

• Animals
• Antibody Formation
• B-Lymphocytes (immunology, physiology)
• Cell Line
• Common Variable Immunodeficiency (genetics, immunology, physiopathology)
• Disease Models, Animal
• Female
• Heterozygote
• Homeostasis
• Homozygote
• Humans
• Lymphocyte Activation (immunology)
• Male
• Mice
• Mice, Inbred C57BL
• Mice, Knockout
• Mutation
• T-Lymphocytes (cytology, immunology)
• Transmembrane Activator and CAML Interactor Protein (genetics, metabolism)